04:42 PM EDT, 09/25/2024 (MT Newswires) -- Eben Tessari, COO, on September 23, 2024, sold 17,500 shares in Kiniksa Pharmaceuticals International (KNSA) for $437,325. Following the Form 4 filing with the SEC, Tessari has control over a total of 116,975 shares of the company, with 116,975 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1730430/000141588924023954/xslF345X05/form4-09252024_080916.xml